Federal contract award
75N98026P00267
THE PURPOSE OF THIS FIRM-FIXED PRICE ORDER IS TO PURCHASE NUCLEIC ACID-BASED REAGENTS FOR IN VIVO TRANSIENT PROTEIN EXPRESSION.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH OLAO |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $60.3K |
| Current contract value | $60.3K |
| Potential contract value / ceiling | $60.3K |
| Start date | May 8, 2026 |
| Current end date | Aug 31, 2026 |
| Potential end date | Aug 31, 2026 |
| Latest award activity | May 7, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 7, 2026 | 0 | $60.3K | THE PURPOSE OF THIS FIRM-FIXED PRICE ORDER IS TO PURCHASE NUCLEIC ACID-BASED REAGENTS FOR IN VIVO TRANSIENT PROTEIN EXPRESSION. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.